Inotiv, Inc. (NOTV)
NASDAQ: NOTV · Real-Time Price · USD
0.6000
+0.0019 (0.32%)
Jan 14, 2026, 1:13 PM EST - Market open
Inotiv Market Cap
Inotiv has a market cap or net worth of $20.62 million as of January 14, 2026. Its market cap has decreased by -83.67% in one year.
Market Cap
20.62M
Enterprise Value
458.10M
1-Year Change
-83.67%
Ranking
Category
Stock Price
$0.60
Market Cap Chart
Since December 1, 1998, Inotiv's market cap has decreased from $20.80M to $20.62M, a decrease of -0.86%. That is a compound annual growth rate of -0.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 13, 2026 | 20.60M | 6.74% |
| Dec 31, 2025 | 19.30M | -82.08% |
| Dec 31, 2024 | 107.70M | 13.73% |
| Dec 29, 2023 | 94.70M | -25.08% |
| Dec 30, 2022 | 126.40M | -87.62% |
| Dec 31, 2021 | 1.02B | 650.66% |
| Dec 31, 2020 | 136.00M | 161.54% |
| Dec 31, 2019 | 52.00M | 300.00% |
| Dec 31, 2018 | 13.00M | -35.64% |
| Dec 29, 2017 | 20.20M | 225.81% |
| Dec 30, 2016 | 6.20M | -49.59% |
| Dec 31, 2015 | 12.30M | -30.11% |
| Dec 31, 2014 | 17.60M | -15.79% |
| Dec 31, 2013 | 20.90M | 100.96% |
| Dec 31, 2012 | 10.40M | 19.54% |
| Dec 30, 2011 | 8.70M | -29.84% |
| Dec 31, 2010 | 12.40M | 143.14% |
| Dec 31, 2009 | 5.10M | -23.88% |
| Dec 31, 2008 | 6.70M | -84.27% |
| Dec 31, 2007 | 42.60M | 58.36% |
| Dec 29, 2006 | 26.90M | -1.82% |
| Dec 30, 2005 | 27.40M | 12.76% |
| Dec 31, 2004 | 24.30M | 34.25% |
| Dec 31, 2003 | 18.10M | 44.80% |
| Dec 31, 2002 | 12.50M | -60.94% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.91B |
| Johnson & Johnson | 505.28B |
| AbbVie | 388.90B |
| UnitedHealth Group | 308.45B |
| AstraZeneca | 294.97B |
| Novartis AG | 274.30B |
| Merck & Co. | 271.01B |
| Novo Nordisk | 263.26B |